Nephrology
-
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study
This article has 16 authors:Reviewed by ScreenIT
-
Vaccination and COVID-19 Dynamics in Dialysis Patients
This article has 7 authors:Reviewed by ScreenIT
-
Similar Rates of AKI during the First Two Waves of COVID-19 in Northern Italy: a single-center study
This article has 20 authors:Reviewed by ScreenIT
-
Humoral response to BNT162b2 mRNA COVID ‐19 vaccine in peritoneal and hemodialysis patients: A comparative study
This article has 8 authors:Reviewed by ScreenIT
-
Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19
This article has 14 authors:Reviewed by ScreenIT
-
Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months follow-up
This article has 18 authors:Reviewed by ScreenIT
-
Effects of immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19
This article has 16 authors:Reviewed by ScreenIT
-
Acute kidney injury in hospitalized patients due to COVID-19
This article has 15 authors:Reviewed by ScreenIT
-
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis
This article has 21 authors:Reviewed by ScreenIT
-
Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis
This article has 13 authors:Reviewed by ScreenIT